65 results

Map_MTV
Ethics

Posted on 24.02.2016

Advancing the standards of ethical business practice worldwide

As a compliance professional, it’s exciting to witness new Codes of Ethics take root worldwide.  Voluntary industry Codes of Ethics serve several important functions.  A credible Code demonstrates industry’s ability to self-regulate, in turn fostering consumer and governmental trust and confidence.  A Code centers stakeholders on the most meaningful business principles that the entire industry […]

By Christopher . L. White, Esq Senior Executive Vice President, General Counsel and Secretary of the Advanced Medical Technology Association (AdvaMed)

Elena_edit
Digital

Posted on 03.12.2015

Ready to innovate. And ripe to transform? How cloud and mobile technologies are poised to transform health at systemic level

Editors’ Note: This blog is the first part of a series on Digital Health, which aims at presenting the challenges of the new digital revolution and demonstrating how digital health is empowering people to better track, manage, and improve their own health. During the European MedTech Forum (2-4 December 2015) follow the conversation and learn from industry […]

By Elena Bonfiglioli Managing Director Health Industry, Public Sector, EMEA, Microsoft

Fotolia_85426172_Subscription_Monthly_M
Ethics

Posted on 15.10.2015

No Plan B

If the activities of the medical technology industry are viewed through the prism of either corruption or honesty, then the draft MedTech Europe Code of Ethical Business Practice could be considered as an endeavor to dissociate the industry from the former.  The draft code does so by providing a clear and stringent framework, ensuring that […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

IVD-Wherearewe
Regulation

Posted on 18.03.2015

New EP, new Commission, another Presidency – Where does the IVD legislation stand?

When the European Parliament finalised their amendments for the Proposal for a Regulation on in vitro diagnostic medical devices in October 2013, they set the scene for a process that has continued through several Council Presidencies. The continued discussions are a reflection of the complexity of the file and the need for careful consideration of the technical aspects of the text, which should lead to the creation of a positive environment for innovation, safety and patient access across Europe.

By Jesús Rueda Rodríguez Director International Affairs MedTech Europe

The future of medtech
Value

Posted on 18.12.2014

My MedTech predictions for 2015 and their impact on our industry

This time last year, I wrote a blogpost about the priorities MedTech Europe would be working on in 2014. This year, I’ve decided to take a different approach. Based on what I see, hear and read every day, I’ll outline what I believe to be the major medtech trends, topics and evolutions we’ll be talking […]

By Serge Bernasconi Chief Executive Officer, MedTech Europe

Continuous Medical Education
Ethics

Posted on 16.10.2014

The Future of Continuing Medical Education

Yesterday, EDMA and Eucomed announced recommendations to respective members on how to improve their Codes of Ethical Business Practice. Chief among their recommendations are a phase out of direct sponsorship and stricter guidelines for indirect sponsorship of healthcare professionals to attend third-party organised conferences. They’ve also committed to working with stakeholders to elaborate new models […]

EU Parliament
Value

Posted on 25.09.2014

DG SANCO or DG ENTR? Our value-based innovations will continue to benefit patients and healthcare systems in Europe

With the summer holidays well and truly behind us, and temperatures outside gradually dropping, I am sure the temperature inside the EU institutions is rising as the EU machine is picking up steam again. Commission portfolios have been handed out, the Commissioners-designate will soon be vetted, and certain competences are being moved from one Directorate-General […]

By Serge Bernasconi Chief Executive Officer, MedTech Europe

Clinical Evidence for medical devices
Access Regulation Value

Posted on 22.05.2014

Let’s close clinical loopholes for devices and not just ‘wallpaper over the cracks’

We’re right in the middle of a year of change in the EU. Europe has begun voting and EU politics may look quite different as a result. New things and new faces may be on the horizon but that doesn’t mean that work has stopped on a file of great importance to the Union’s more […]

By Serge Bernasconi Chief Executive Officer, MedTech Europe

personalised medicine
Access Value

Posted on 13.05.2014

How losing the battle for access to personalised medicine can mean losing the fight for survival: The story of Patricia Garcia-Prieto

“How much is my life worth?” Patricia Garcia-Prieto, professor of Organisational Behaviour at the Solvay Brussels School of Economics and Management and a mother of six and 11-year olds has asked this question multiple times. In her video, as a patient representative on a panel, she has been vocal about this thought that passed her mind every day. […]

By Denis Horgan Executive Director, European Alliance for Personalised Medicine